Hepatology International

, Volume 1, Issue 3, pp 387–393 | Cite as

Prevalence and risk factors for hepatitis C infection in rural north Vietnam

  • Van Thi Thuy Nguyen
  • Mary-Louise McLaws
  • Gregory J. Dore
Original Paper

Abstract

Background

In Vietnam, the prevalence of hepatitis C virus (HCV) infection among injecting drug users and patients with liver disease is known to be high, yet the magnitude of HCV in the general population, particularly in rural areas, has not been clearly estimated. A community-based study was used to determine the prevalence of HCV infection in a rural population of north Vietnam and explore risk factors associated with HCV acquisition.

Method

A community-based viral hepatitis seroprevalence study using a multistage sampling method to recruit participants was undertaken. The study population size (n = 837) had been determined on the basis of estimated hepatitis B virus (HBV) prevalence. Information on demography and potential risk factors were obtained using face-to-face interviews, and all selected participants were tested for anti-HCV antibody.

Results

HCV prevalence in the study population was 1.0% (95% CI: 0.4%–1.9%). Hospital admission (adjusted odds ratio [AOR]: 7.19; 95% CI: 1.59–32.53; P = .01) and having tattoos (AOR: 13.37: 95% CI: 1.86–96.15; P = .01) were independent predictors of HCV infection, and farmers were less likely to have HCV infection than those in other occupations (AOR: 0.19; 95% CI: 0.04–0.84; P = .02).

Conclusion

The prevalence of HCV infection is low in the general rural population in northern Vietnam. An association between HCV infection and hospital admission and tattoos indicate a need to improve the standards of infection control in healthcare and other settings in this region.

Keywords

Prevalence Risk factors Hepatitis C infection Rural population Vietnam 

References

  1. 1.
    World Health Organization. Hepatitis C. Fact sheet No 164 [Online]; October 2000. Available at: http://www.who.int/mediacentre/factsheets/fs164/en/. Accessed November 25, 2006
  2. 2.
    Ratanasuwan W, Sonji A, Tiengrim S, Techasathit W, Suwanagool S. Serological survey of viral hepatitis A, B, and C at Thai Central Region and Bangkok: a population base study. Southeast Asian J Trop Med Public Health 2004;35:416–420PubMedGoogle Scholar
  3. 3.
    Ishida T, Takao S, Settheetham-Ishida W, Tiwawech D. Prevalence of hepatitis B and C virus infection in rural ethnic populations of Northern Thailand. J Clin Virol 2002;24:31–35PubMedCrossRefGoogle Scholar
  4. 4.
    Pramoolsinsap C, Sumalnop K, Busagorn N, Kurathong S. Prevalence and outcomes of HBV and anti-HCV seropositive patients with chronic liver disease and hepatocellular carcinoma. Southeast Asian J Trop Med Public Health 1992;23:6–11PubMedGoogle Scholar
  5. 5.
    Luksamijarulkul P, Plucktaweesak S. High hepatitis C seroprevalence in Thai intravenous drug abusers and qualitative risk analysis. Southeast Asian J Trop Med Public Health 1996;27:654–658PubMedGoogle Scholar
  6. 6.
    Hoang DM. Lymphocyte B and C among people with anti-HCV positive in different populations in Hai Phong [dissertation, in Vietnamese]. Hanoi: The Military Institute of Medicine, The Ministry of Education and Training, Vietnam; 2003Google Scholar
  7. 7.
    Pham S, Dao DD, Bui H, et al. Makers of hepatitis C and B virus infections among blood donors in Ho Chi Minh and Hanoi, Vietnam. Clin Diagn Lab Immunol 1994;1:413–418Google Scholar
  8. 8.
    Nakata S, Pham S, Dao D, et al. Hepatitis C and B virus infection in population at low or high risk in Ho Chi Minh and Hanoi, Viet nam. J Gastroenterol Hepatol 1994;9(4):416–419PubMedGoogle Scholar
  9. 9.
    La TN. Hepatitis B and C infection in different population groups in Southern Vietnam and implication for seeking blood donors [PhD dissertation, in Vietnamese]. Hanoi: Hanoi Medical University; 1995Google Scholar
  10. 10.
    Hoang TL, Nguyen TV, Do TD, et al. Hepatitis B and C infection in Thanh Hoa province [in Vietnamese]. J Prev Med 1999;9:5–9Google Scholar
  11. 11.
    Tran HT-T, Ushijima H, Quang VX, et al. Prevalence of hepatitis virus types B through E and genotypic distribution of HBV and HCV in Ho Chi Minh City, Vietnam. Hepatol Res 2003;26:275–280PubMedCrossRefGoogle Scholar
  12. 12.
    Kakumu S, Sato K, Morishita T, et al. Prevalence of hepatitis B, hepatitis C, and GB virus C/hepatitis G virus infections in liver disease patients and inhabitants in Ho Chi Minh, Vietnam. J Med Virol 1998;54:243–248PubMedCrossRefGoogle Scholar
  13. 13.
    Corwin AL, Dai TC, Duc DD, et al. Acute viral hepatitis in Hanoi, Viet Nam. Trans R Soc Trop Med Hyg 1996;90:647PubMedCrossRefGoogle Scholar
  14. 14.
    Nguyen VT, Hoang NT, Fields H. Hepatitis A, B, C and D infections in different groups and the implications for producing and using hepatitis B vaccine in Vietnam [in Vietnamese]. J Hyg Prev Med 1992;2(1):6–15Google Scholar
  15. 15.
    Vu VK, Ha VM, Nguyen TA, et al. The prevalence of hepatitis C virus infection among patients with chronic liver disease. J Gastroenterol Hepatol 1997;12:A6Google Scholar
  16. 16.
    Nguyen VTT, McLaws M, Dore G. Highly endemic hepatitis B infection in rural Vietnam. J Gastroenterol Hepatol. In press. Google Scholar
  17. 17.
    Dore GJ, Law M, MacDonald M, Kaldor JM. Epidemiology of hepatitis C virus infection in Australia. J Clin Virol 2003;26:171–184PubMedCrossRefGoogle Scholar
  18. 18.
    Shin HR, Kim JY, Ohno T, et al. Prevalence and risk factors of hepatitis C virus infection among Koreans in rural area of Korea. Hepatol Res 2000;17:185PubMedCrossRefGoogle Scholar
  19. 19.
    Memon MI, Memon MA, Hepatitis C. an epidemiological review. J Viral Hepat 2002;9:84–100PubMedCrossRefGoogle Scholar
  20. 20.
    Sanchez JL, Sjogren MH, Callahan JD, et al. Hepatitis C in Peru: risk factors for infection, potential iatrogenic transmission, and genotype distribution. Am J Trop Med Hyg 2000;63:242–248PubMedGoogle Scholar
  21. 21.
    Di Bisceglie AM. Hepatitis C. Lancet 1998;351:351–355PubMedCrossRefGoogle Scholar
  22. 22.
    Nishioka SdA, Gyorkos TW. Tattoos as risk factors for transfusion-transmitted diseases. Int J Infect Dis 2001;5:27–34CrossRefGoogle Scholar
  23. 23.
    Mele A, Spada E, Sagliocca L, Ragni P, Tosti ME, Gallo G, et al. Risk of parenterally transmitted hepatitis following exposure to surgery or other invasive procedures: results from the hepatitis surveillance system in Italy. J Hepatol 2001;35:284–289PubMedCrossRefGoogle Scholar
  24. 24.
    World Health Organization. Technical activities. Injection safety; 2006. Available at: http://www.who.int/patientsafety/activities/technical/injection_safety/en/. Accessed November 13, 2006
  25. 25.
    Kane A, Lloyd J, Zaffran M, Simonsen L, Kane M. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bull World Health Organ 1999;77(10):801–807PubMedGoogle Scholar
  26. 26.
    Brandao AB, Fuchs SC. Risk factors for hepatitis C virus infection among blood donors in southern Brazil: a case-control study. BMC Gastroenterol 2002;2:18PubMedCrossRefGoogle Scholar
  27. 27.
    Mele A, Tosti ME, Marzolini, Moiraghi, Ragni, Gallo, et al. Prevention of hepatitis C in Italy: lessons from surveillance of type-specific acute viral hepatitis. J Viral Hepat 2000;7:30–35Google Scholar
  28. 28.
    Akhtar S, Younus M, Adil S, Jafri SH, Hassan F. Hepatitis C virus infection in asymptomatic male volunteer blood donors in Karachi, Pakistan. J Viral Hepat 2004;11:527–535PubMedCrossRefGoogle Scholar
  29. 29.
    Domínguez À, Bruguera M, Vidal J, Plans P, Salleras L. Community-based seroepidemiological survey of HCV infection in Catalonia, Spain. J Med Virol 2001;65:688–693PubMedCrossRefGoogle Scholar
  30. 30.
    Chiaramonte M, Stroffolini T, Lorenzoni U, Minniti F, Conti S, Floreani A, et al. Risk factors in community-acquired chronic hepatitis C virus infection: a case-control study in Italy. J Hepatol 1996;24:129PubMedCrossRefGoogle Scholar
  31. 31.
    Forns X, Martínez-Bauer E, Feliu A, García-Retortillo M, Martín M, Gay E, et al. Nosocomial transmission of HCV in the liver unit of a tertiary care center. Hepatology 2005;41:115–122PubMedCrossRefGoogle Scholar
  32. 32.
    Stefano RD, Stroffolini T, Ferraro D, Usticano A, Valenza LM, Montalbano L, et al. Endemic hepatitis C virus infection in a Sicilian town: further evidence for iatrogenic transmission. J Med Virol 2002;67:339–344PubMedCrossRefGoogle Scholar
  33. 33.
    Catalani C, Biggeri A, Gottard A, Benvenuti M, Frati E, Cecchini C. Prevalence of HCV infection among health care workers in a hospital in central Italy. Eur J Epidemiol 2004;19:73–77PubMedCrossRefGoogle Scholar
  34. 34.
    Polish LB, Tong MJ, Co RL, Coleman PJ, Alter MJ. Risk factors for hepatitis C virus infection among health care personnel in a community hospital. Am J Infect Control 1993;21:196–200PubMedCrossRefGoogle Scholar
  35. 35.
    Yazdanpanah Y, De Carli G, Migueres B, Lot F, Campins M, Colombo C, et al. Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control study. Clin Infect Dis 2005;41:1423–1430PubMedCrossRefGoogle Scholar
  36. 36.
    Luksamijarulkul P, Thammata N, Sujirarat D, Tiloklurs M. Hepatitis C virus infection among Thai blood donors: antibody prevalence, risk factors and development of risk screening form. Southeast Asian J Trop Med Public Health 2004;35:147–154PubMedGoogle Scholar

Copyright information

© Asian Pacific Association for the Study of the Liver 2007

Authors and Affiliations

  • Van Thi Thuy Nguyen
    • 1
  • Mary-Louise McLaws
    • 1
  • Gregory J. Dore
    • 2
  1. 1.School of Public Health and Community MedicineUniversity of New South WalesSydneyAustralia
  2. 2.National Centre in HIV Epidemiology and Clinical ResearchUniversity of New South WalesDarlinghurstAustralia

Personalised recommendations